Symlin



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 31.4%
Diabetes Mellitus Non-insulin-dependent 18.8%
Type 1 Diabetes Mellitus 17.4%
Diabetes Mellitus Insulin-dependent 11.6%
Drug Use For Unknown Indication 11.5%
Diabetes Mellitus 5.8%
Weight Decreased 0.7%
Glucose Tolerance Impaired 0.4%
Product Used For Unknown Indication 0.4%
Weight Control 0.4%
Insulin Resistance 0.3%
Neuralgia 0.3%
Blood Cholesterol Increased 0.2%
Insulin Resistant Diabetes 0.2%
Catheterisation Cardiac 0.1%
Hypertension 0.1%
Thyroid Disorder 0.1%
Arthropathy 0.0%
Blood Pressure Abnormal 0.0%
Blood Triglycerides Increased 0.0%
Nausea 20.0%
Weight Decreased 15.6%
Blood Glucose Increased 14.8%
Injection Site Pain 11.2%
Weight Increased 5.7%
Vomiting 5.4%
Drug Ineffective 4.1%
Medication Error 3.0%
Wrong Drug Administered 2.6%
Tremor 2.5%
Injection Site Bruising 1.8%
Hypoglycaemia 1.7%
Incorrect Dose Administered 1.7%
Drug Effect Decreased 1.6%
Blood Glucose Decreased 1.5%
Urticaria 1.5%
Injection Site Irritation 1.4%
Vision Blurred 1.4%
Treatment Noncompliance 1.4%
Diarrhoea 1.2%
Secondary
Type 2 Diabetes Mellitus 45.5%
Type 1 Diabetes Mellitus 21.3%
Diabetes Mellitus 12.0%
Drug Use For Unknown Indication 5.9%
Diabetes Mellitus Non-insulin-dependent 5.2%
Insulin Resistance 2.7%
Hypertension 1.4%
Diabetes Mellitus Insulin-dependent 0.9%
Gastrointestinal Disorder 0.9%
Infection Prophylaxis 0.9%
Blood Cholesterol Increased 0.7%
Blood Glucose 0.5%
Cardiac Disorder 0.5%
Osteoporosis 0.5%
Arthritis 0.2%
Blood Cholesterol Decreased 0.2%
Cardiac Pacemaker Insertion 0.2%
Diabetic Foot Infection 0.2%
Fluid Retention 0.2%
Gout 0.2%
Nausea 24.2%
Blood Glucose Increased 14.6%
Weight Increased 13.4%
Weight Decreased 5.7%
Injection Site Pain 5.1%
Vomiting 5.1%
Drug Prescribing Error 4.5%
Urticaria 3.8%
Drug Effect Decreased 3.2%
Injection Site Haematoma 3.2%
Hypoglycaemia 2.5%
Increased Appetite 1.9%
Rash Pruritic 1.9%
Stomach Discomfort 1.9%
Vision Blurred 1.9%
Wheezing 1.9%
Anaphylactoid Reaction 1.3%
Dizziness 1.3%
Drug Ineffective 1.3%
Glycosylated Haemoglobin Increased 1.3%
Concomitant
Type 2 Diabetes Mellitus 27.4%
Diabetes Mellitus 20.2%
Product Used For Unknown Indication 11.8%
Drug Use For Unknown Indication 4.7%
Hypertension 4.0%
Blood Pressure 3.4%
Pain 3.3%
Cardiac Disorder 3.0%
Diabetes Mellitus Non-insulin-dependent 2.7%
Back Pain 2.4%
Type 1 Diabetes Mellitus 2.3%
Weight Loss Diet 2.0%
Blood Cholesterol 1.7%
Depression 1.7%
Gastrooesophageal Reflux Disease 1.7%
Hypersensitivity 1.6%
Insulin-requiring Type 2 Diabetes Mellitus 1.6%
Renal Disorder 1.6%
Sleep Disorder 1.6%
Osteopenia 1.4%
Weight Decreased 27.0%
Weight Increased 13.2%
Blood Glucose Increased 8.6%
Loss Of Consciousness 5.9%
Nausea 5.9%
Urticaria 3.9%
Drug Ineffective 3.3%
Vision Blurred 3.3%
Wrong Technique In Drug Usage Process 3.3%
Flushing 2.6%
Hyperlipidaemia 2.6%
Myocardial Infarction 2.6%
Throat Irritation 2.6%
Tremor 2.6%
Vomiting 2.6%
Diabetes Mellitus 2.0%
Dyspnoea 2.0%
Gastrointestinal Haemorrhage 2.0%
Hospitalisation 2.0%
Nervousness 2.0%
Interacting
Type 2 Diabetes Mellitus 42.9%
Blood Cholesterol Increased 28.6%
Thyroid Disorder 14.3%
Gastric Disorder 10.7%
Neuralgia 1.8%
Type 1 Diabetes Mellitus 1.8%
Gastric Disorder 88.9%
Weight Increased 11.1%